Characterization of the EMS1 Gene and its Product, Human Cortactin

References

• Altschul S. F., Gish W., Miller W., Myers E. W., Lipman D. J. Basic local alignment search tool. J. Mol. Biol. 1990; 215: 403–410
   PubMed Web of Science ®Google Scholar
• Borg A., Sigurdsson H., Clark G. M., Fernö M., Fuqua S. A.W., Olsson H., Killander D., McGurie W. L. Association of int-2/hst-1 coamplification in primary breast cancer with hormone-dependent phenotype and poor prognosis. Br. J. Cancer 1991; 63: 136–142
   PubMed Web of Science ®Google Scholar
• Bringuier P., Tamimi Y., Schuuring E., Schalken J. Expression of cyclin D1 and EMS1 in bladder tumors; relationship with chromosome 11q13 amplification. Oncogene 1996; 12: 1747–1753
   PubMed Web of Science ®Google Scholar
• Brodrug S. E., Warner B. J., Bath M. L., Lindeman G. J., Harris A. W., Adams J. M. Cyclin D1 transgene impedes lymphocyte maturation and collaborates in lymphoma-genesis with the myc gene. EMBO J. 1994; 13: 2124–2130
   PubMed Web of Science ®Google Scholar
• Brookes S., Lammie G. A., Schuuring E., de Boer C., Michalides R., Dickson C., Peters G. Amplified region of chromosome band 11q13 in breast and squamous cell carcinomas encompasses three CpG islands telomeric of FGF3. including the expressed gene. EMS1. Genes, Chrom. Cancer 1993; 6: 222–231
   PubMed Web of Science ®Google Scholar
• Brzeska H., Lynch T. J., Martin B., Korn E. D. The localization and sequence of the phosphorylation sites of Acanthamoeba myosins I. An improved method for locating the phosphorylated amino acid. J. Biol. Chem. 1989; 264: 19340–19348
   PubMed Web of Science ®Google Scholar
• Burridge K., Fath K., Kelly T., Nuckolls G., Turner C. Focal adhesions: Transmembrane junctions between the extracellular matrix and the cytoskeleton. Ann. Rev. Cell Biol. 1988; 4: 487–525
   PubMedGoogle Scholar
• Burridge K., Turner C. E., Romer L. H. Tyrosine phosphorylation of paxillin and pp125FAK accompanies cell adhesion to extracellular matrix: a role in cytoskeletal assembly. J. Cell. Biol. 1992; 119: 893–903
   PubMed Web of Science ®Google Scholar
• Chou P. Y., Fasman G. D. Prediction of the secondary structure of proteins from their amino acid sequence. Adv. Enzymol. Relat. Areas Mol. Biol. 1978; 47: 45–148
   PubMedGoogle Scholar
• Clark E. A., Brugge J. S. Integrins and signal transduction pathways: the road taken. Science 1995; 268: 233–237
   PubMed Web of Science ®Google Scholar
• Dai Z., Pendergast A. M. Abi-2, a novel SH3-containing protein interacts with the c-Abl tyrosine kinase and modulates c-Abl transforming activity. Genes Dev. 1995; 9: 2569–2582
   PubMed Web of Science ®Google Scholar
• De Boer C. J., van Krieken J. H.J.M., Kluin-Nelemans H. C., Kluin P. M., Schuuring E. Cyclin DI messenger RNA overexpression as a marker for mantle cell lymphoma. Oncogene 1995; 10: 1833–1840
   PubMed Web of Science ®Google Scholar
• De Boer C. J., Schuuring E., Dreef E., Kluin Ph. M., van Krieken J. H.J.M. Cyclin D1 protein overexpression as a marker for mantle cell lymphoma. Blood 1995; 86: 2715–2723
   PubMed Web of Science ®Google Scholar
• De Kroon J. F., Kluin-Nelemans H. C., Kluin P. M., Schuuring E., van Bergen C. A., Oving I., Wessels H., Willemze R., Falkenburg F. H. Characterization of a novel malignant B cell line with t(11;14) and t(4;11) established from a patient with acute monoblastic leukemia. Exp. Hematol. 1997; 25: 1062–1068
   PubMed Web of Science ®Google Scholar
• Devereux J., Haeberli P., Smithies O. A comprehensive set of sequence analysis programs for the VAX. Nucl. Acids Res. 1984; 12: 387–395
   PubMed Web of Science ®Google Scholar
• Drubin D. G., Mulholland J., Zhu Z. M., Botstein D. Homology of a yeast actin-binding protein to signal transduction proteins and myosin-I. Nature 1990; 343: 288–290
   PubMed Web of Science ®Google Scholar
• Durieu-Trautmann O., Chaverot N., Cazaubon S., Strosberg A. D., Couraud P. O. Intercellular adhesion molecule 1 activation induces tyrosine phosphorylation of the cytoskeleton-associated protein cortactin in brain micro-vessel endothelial cells. J. Biol. Chem. 1994; 269: 12536–12540
   PubMed Web of Science ®Google Scholar
• Gould K. L., Bretscher A., Esch F. S., Hunter T. cDNA cloning and sequencing of the protein–tyrosine kinase substrate, ezrin, reveals homology to band 4.1. EMBO J. 1989; 8: 4133–4142
   PubMed Web of Science ®Google Scholar
• Gunning P., Leavitt J., Muscat G., Ng S. Y., Kedes L. A human beta-actin expression vector system directs high-level accumulation of antisense transcripts. Proc. Natl. Acad. Sci. USA 1987; 84: 4831–4835
   PubMed Web of Science ®Google Scholar
• Hall M., Peters G. Genetic alterations of cyclins, cyclin-dependent kinases, and Cdk inhibitors in human cancer. Adv. Cancer Res. 1996; 68: 67–108
   PubMed Web of Science ®Google Scholar
• Hirano T., Kinoshita N., Morikawa K., Yanagida M. Snap helix with knob and hole: essential repeats in S. pombe nuclear protein nuc2+. Cell 1990; 60: 319–328
   PubMed Web of Science ®Google Scholar
• Hiura K., Lim S., Little S. P., Lin S., Sato M. Differentiation dependent expression of tensin and cortactin in chicken osteoclasts. Cell Motil. Cytoskeletoni 1995; 30: 272–284
   PubMed Web of Science ®Google Scholar
• Huang C., Ni Y. S., Wang T., Gao Y. M., Haudenschild C. C., Zhan X. Down regulation of the filamentous actin cross linking activity of cortactin by src mediated tyrosine phosphorylation. J. Biol. Chem. 1997; 272: 13911–13915
   PubMed Web of Science ®Google Scholar
• Hui R., Campbell D. H., Lee C. S.L., McCaul K., Horsfall D. J., Musgrove E. A., Daly R. J., Seshadri R., Sutherland R. L. EMSI amplification can occur independently of CCNDI or int2 amplification at 11q13 and may identify different phenotypes in primary breast cancer. Oncogene 1997; 15: 1617–1623
   PubMed Web of Science ®Google Scholar
• Kanner S. B., Reynolds A. B., Vines R. R., Parsons J. T. Monoclonal antibodies to individual tyrosine-phosphorylated protein substrates of oncogene-encoded tyrosine kinases. Proc. Natl. Acad. Sci. USA 1990; 87: 3328–3332
   PubMed Web of Science ®Google Scholar
• Karlseder J., Zeillinger R., Schneeberger C., Czerwenka K., Speiser P., Kubista E., Birnbaum D., Gaudray P., Theillet C. Patterns of DNA amplification at band q13 of chromosome 11 in human breast cancer. Genes Chrom. Cancer 1994; 9: 42–48
   PubMed Web of Science ®Google Scholar
• Kitagawa Y., Ueda M., Ando N., Shinozawa Y., Shimizu N., Abe O. Significance of int-2/hst-1 coamplification as a prognostic factor in patients with esophageal squamous carcinoma. Cancer Res. 1991; 51: 1501–1508
   Web of Science ®Google Scholar
• Kitamura D., Kaneko H., Miyagoe Y., Ariyasu T., Wanatabe T. Isolation and characterization of a novel human gene expressed specifically in the cells of hematopoietic lineage. Nucleic Acids. Res. 1989; 17: 9367–9379
   PubMed Web of Science ®Google Scholar
• Kitamura D., Kaneko H., Taniuchi I., Akagi K., Yamamura K., Wanatabe T. Molecular cloning and characterization of mouse HSI. Biochem. Biophts. Res. Commun. 1995; 208: 1137–1146
   PubMed Web of Science ®Google Scholar
• Kozak M. Compilation and analysis of sequences upstream from the translational start site in eukaryotic mRNAs. Nucleic Acids Res. 1984; 12: 857–872
   PubMed Web of Science ®Google Scholar
• Kyte J., Doolittle R. F. A simple method for displaying the hydropathic character of a protein. J. Mol. Biol. 1982; 157: 105–132
   PubMed Web of Science ®Google Scholar
• Lovec H., Sewing A., Lucibello F. C., Müller R., Möröy T. Oncogenic activity of cyclin D1 revealed through cooperation with Ha-ras: link between cell cycle control and malignant transformation. Oncogene 1994; 9: 323–326
   PubMed Web of Science ®Google Scholar
• Lovec H., Grzeschiczek A., Kowalski M., Möröy T. Cyclin D1/bcl-1 cooperates with myc genes in the generation of B-cell lymphoma in transgenic mice. EMBO J. 1994; 13: 3487–3495
   PubMed Web of Science ®Google Scholar
• Luna E. J., Hitt A. L. Cytoskeleton–plasma membrane interactions. Science 1992; 258: 955–964
   PubMed Web of Science ®Google Scholar
• Lux S. E., John K. M., Bennett V. Analysis of cDNA for human erythrocyte ankyrin indicates a repeated structure with homology to tissue-differentiation and cell-cycle control proteins. Nature 1990; 344: 36–42
   PubMed Web of Science ®Google Scholar
• Maa M. C., Wilson L. K., Moyers J. S., Vines R. R., Parsons J. T., Parsons S. J. Identification and characterization of a cytoskeleton-associated, epidermal growth factor sensitive pp60c-src substrate. Oncogene 1992; 7: 2429–2438
   PubMed Web of Science ®Google Scholar
• Marchisio P. C., Cirillo D., Teti A., Zambonin-Zallone A., Tarone G. Rous sarcoma virus-transformed fibroblasts and cells of monocytic origin display a peculiar dot-like organization of cytoskeletal proteins involved in microfilament-membrane interactions. Exp. Cell Res. 1987; 169: 202–214
   PubMed Web of Science ®Google Scholar
• Maruyama S., Kurosaki T., Sada K., Yamanashi Y., Yamamoto T., Yamamura H. Physical and functional association of cortactin with Syk in human leukemic cell line K562. J. Biol. Chem. 1996; 271: 6631–6635
   PubMed Web of Science ®Google Scholar
• Miglarese M. R., Mannion-Henderson J., Wu H., Parsons T., Bender T. P. The protein tyrosine kinase substrate cortactin is differentially expressed in murine B lymphoid tumors. Oncogene 1994; 9: 1989–1997
   PubMed Web of Science ®Google Scholar
• Morgenstern J. P., Land H. A series of mammalian expression vectors and characterisation of their expression of a reporter gene in stably and transiently transfected cells. Nucleic Acids Res. 1990; 18: 1068
   PubMed Web of Science ®Google Scholar
• Muller D., Millon R., Lidereau R., Engelmann A., Bronner G., Flesch H., Eber M., Methlin G., Abecassis J. Frequent amplification of 11q13 DNA markers is associated with lymph node involvement in human head and neck squamous cell carcinomas. Eur. J. Cancer B. Oral Oncol. 1994; 30B: 113–120
   PubMed Web of Science ®Google Scholar
• Nakagawa H., Wang T. C., Zukerberg L., Odze R., Togawa K., May G. H.W., Wilson J., Rustgi A. K. The targeting of the cyclin DI oncogene by an Epstein-Barr virus promoter in transgenic mice causes dyplasia in the tongue, esophagus and forestomach. Oncogene 1997; 14: 1185–1190
   PubMed Web of Science ®Google Scholar
• Okamura H., Resh M. D. P80/85 cortactin associates with the src SH2 domain and colocalizes with v-src in transformed cells. J. Biol. Chem. 1995; 270: 26613–26618
   PubMed Web of Science ®Google Scholar
• Ozawa K., Kashiwada K., Takahashi M., Sobue K. Translocation of cortactin (p80/85) to the actin-based cytoskeleton during thrombin receptor-mediated platelet activation. Exp. Cell Res. 1995; 221: 197–204
   PubMed Web of Science ®Google Scholar
• Pawson T. Protein modules and signalling networks. Nature 1995; 373: 573–580
   PubMed Web of Science ®Google Scholar
• Peters G., Fantl V., Smith R., Brookes S., Dickson C. Chromosome 11q13 markers and D-type cyclins in breast cancer. Breast Cancer Res. Treat. 1995; 33: 125–135
   PubMed Web of Science ®Google Scholar
• Ren R., Mayer B. J., Cicchetti P., Baltimore D. Identification of a ten-amino acid proline-rich SH3 binding site. Science 1993; 259: 1157–1161
   PubMed Web of Science ®Google Scholar
• Saraste M., Sibbald P. R., Wittinghofer A. The Ploop – a common motif in ATP- and GTP-binding proteins. Trends Biochem. Sci. 1990; 15: 430–434
   PubMed Web of Science ®Google Scholar
• Sartor O., Robbins K. C. Substrate specificity for normal but not mutationally activated variants of src family kinases. J. Biol. Chem. 1993; 268: 21014–21020
   PubMed Web of Science ®Google Scholar
• Schuuring E., van der Leede B. J., Willems R., Daams H., van der Valk M., van de Vijver M., van Leeuwen F., Sonnenberg A., Nusse R. Differentiation-dependent expression of provirus-activated INT1 oncogene in clonal cell lines derived from a mouse mammary tumor. Oncogene 1990; 5: 459–465
   PubMed Web of Science ®Google Scholar
• Schuuring E., Verhoeven E., van Tinteren H., Peterse J. L., Nunnink B., Thunissen F. B.J.M., Devilee P., Cornelisse C. J., van de Vijver M. J., Mooi W. J., Michalides R. J.A.M. Amplification of genes within the chromosome 11q13 region is indicative of poor prognosis in patients with operable breast cancer. Cancer Res. 1992; 52: 5229–5234
   PubMed Web of Science ®Google Scholar
• Schuuring E., Verhoeven E., Mooi W. J., Michalides R. J.A.M. Identification and cloning of two over-expressed genes, U21B31/PRAD1 and EMS1. within the amplified chromosome 11q13 region in human carcinomas. Oncogene 1992; 7: 355–361
   PubMed Web of Science ®Google Scholar
• Schuuring E., Verhoeven E., Litvinov S., Michalides R. J.A.M. The product of the EMS1 gene, amplified and overexpressed in human carcinomas, is homologous to a v-src substrate and is located in cell–substratum contact sites. Mol. Cell. Biol. 1993; 13: 2891–2898
   PubMed Web of Science ®Google Scholar
• Schuuring E. The involvement of the chromosome 11 q 13 region in human malignancies: cyclin D1 and EMS1 are two new candidate oncogenes. Gene 1995; 159: 83–96
   PubMed Web of Science ®Google Scholar
• Schwartz R. M., Dayhoff M. O. Atlas of Protein Sequence and Structure. National Biomedical Research Foundation, Washington, D.C. 1979
   Google Scholar
• Simms L. A., Zou T. T., Young J., Shi Y. Q., Lei J. Y., Appel R., Rhyu M. G., Sugimura H., Chenevixtrench G., Souza R. F., Meltzer S. J., Leggett B. A. Apparent protection from instability of repeat sequences in cancer related genes in replication error positive gastrointestinal cancers. Oncogene 1997; 14: 2613–2618
   PubMed Web of Science ®Google Scholar
• Sparks A. B., Rider J., Hoffman N., Fowlkes D., Quilliam L., Kay B. Distinct ligand preferences of Src homology 3 domains from Src, Yes, AbI, Cortactin, p53bp2, PLC-γ, Crk and Grb2. Proc. Natl. Acad. Sci. USA 1996; 93: 1540–1544
   PubMed Web of Science ®Google Scholar
• Sparks A. B., Hoffman N. G., McConnell S. J., Fowlkes D., Kay B. K. Cloning of ligand targets: sytematic isolation of SH3 domain-containing proteins. Nature Biotech. 1996; 14: 741–744
   PubMed Web of Science ®Google Scholar
• Takemoto Y., Furuta M., Li X.-K., Strong-Parks W. J., Hashimoto Y. LckBP1, a proline-rich protein expressed in haematopoietic cells, directly associates with the SH3 domain of protein tyrosine kinase p56lck. EMBO J. 1995; 3: 3403–3414
   Google Scholar
• Takes R. T., Baatenburg de Jong R. J., Schuuring E., Hermans J., Vis A. A., Litvinov S. V., van Krieken J. H.J.M. Markers for assessment of nodal metastasis in laryngeal carcinoma. Arch. Otolaryngol. Head Neck Surg. 1997; 123: 412–419
   PubMed Web of Science ®Google Scholar
• Talay S. R., Valentin-Weigand P., Jerlstrom P. G., Timmis K. N., Chhatwal G. S. Fibronectin-binding protein of Streptococcus pyogenes: sequence of the binding domain involved in adherence of streptococci to epithelial cells. Infect. Immun. 1992; 60: 3837–3844
   PubMed Web of Science ®Google Scholar
• Tarone G., Cirillo D., Giancotti F. G., Comoglio P. M., Marchisio P. C. Rous sarcoma virus-transformed fibroblasts adhere primarily at discrete protrusions of the ventral membrane called podosomes. Exp. Cell Res. 1985; 159: 141–157
   PubMed Web of Science ®Google Scholar
• Thomas S. M., Soriano P., Imamoto A. Specific and redundant roles of src and fyn in organizing the cytoskeleton. Nature 1995; 376: 267–271
   PubMed Web of Science ®Google Scholar
• Tsuda H., Hirohashi S., Shimosato Y., Hirota T., Tsugane S., Yamamoto H., Miyajima N., Toyoshima K., Yamamoto T., Yokota J., Yoshida T., Sakamoto H., Terada M., Sugimura T. Correlation between long-term survival in breast cancer patients and amplification of two putative oncogene-coamplification units: hstl/int2 and c-erbB2/earl. Cancer Res. 1989; 49: 3104–3108
   PubMed Web of Science ®Google Scholar
• Vaandrager J., Schuuring E., Zwikstra E., De Boer C. J., Kleiverda K. K., van Krieken J. H.J.M., Kluin-Nelemans H. C., van Ommen G. J.B., Raap T. K., Kluin P. M. Direct visualization of dispersed 11q13 chromosomal translocations in mantle cell lymphoma by multicolor DNA fiber fluorescence in situ hybridization. Blood 1996; 88: 1177–1182
   PubMed Web of Science ®Google Scholar
• Van Damme H., Brok H., Schuuring-Scholtes W. H.M., Schuuring E. The redistribution of cortactin into cell–matrix contact sites in human carcinoma cells with 11q13 amplification is associated with both overexpression and post-translational modification. J. Biol. Chem. 1997; 272: 7374–7380
   PubMed Web of Science ®Google Scholar
• Vuori K., Ruoslahti E. Tyrosine phosphorylation of p130cas and cortactin accompanies integrin-mediated cell adhesion to extracellular matrix. J. Biol. Chem. 1995; 270: 22259–22262
   PubMed Web of Science ®Google Scholar
• Wang T. C., Cardiff R. D., Zukerberg L., Lees E., Arnold A., Schmidt E. V. Mammary hyperplasia and carcinoma in MMTV-cyclin D1 transgenic mice. Nature 1994; 369: 669–671
   PubMed Web of Science ®Google Scholar
• Wang B., Mysliwiec T., Krainc D., Jensen R. A., Sonoda G., Testa J. R., Golemis E. A., Kruh G. D. Identification of ArgBP1, an Arg protein tyrosine kinase binding protein that is the human homologue of a CNS-specific Xenopus gene. Oncogene 1996; 12: 1921–1929
   PubMed Web of Science ®Google Scholar
• Williams M. E., Gaffey M. J., Weiss L. M., Wilczynski S. P., Schuuring E., Levine P. A. Chromosome 11q13 amplification in head and neck squamous cell carcinoma. Arch. Otolaryngol. Head Neck Surg. 1993; 119: 1238–1243
   PubMed Web of Science ®Google Scholar
• Wong S., Reynolds A. B., Papkoff J. Platelet activation leads to increased c-src kinase activity and association of c-src with an 85 kDa tyrosine phosphoprotein. Oncogene 1992; 7: 2407–2415
   PubMed Web of Science ®Google Scholar
• Wu H., Reynolds A. B., Kanner S. B., Vines R. R., Parsons J. T. Identification and characterization of a novel cytoskeleton-associated pp60src substrate. Mol. Cell Biol. 1992; 11: 5113–5124
   Web of Science ®Google Scholar
• Wu H., Parsons J. T. Cortactin, an 80/85-kilodalton pp605src substrate, is a filamentous actin-binding protein enriched in the cell cortex. J. Cell. Biol. 1993; 120: 1417–1426
   PubMed Web of Science ®Google Scholar
• Yamanashi Y., Okada M., Semba T., Yamori T., Umemori H., Tsunasawa S., Toyoshima K., Kitamura D., Watanabe T., Yamamoto T. Identification of HS1 protein as a major substrate of protein-tyrosine kinase(s) upon B-cell antigen receptor-mediated signaling. Proc. Natl. Acad. Sci. USA 1993; 90: 3631–3635
   PubMed Web of Science ®Google Scholar
• Zhan X., Hu X., Hampton B., Burgess W. H., Friesel R., Maciag T. Murine cortactin is phosphorylated in response to fibroblast growth factor-1 on tyrosine residues late in G1 phase of the BALB/c 3T3 cell cycle. J. Biol. Chem. 1993; 268: 24427–24431
   PubMed Web of Science ®Google Scholar
• Zhan X., Plourde C., Hu X., Friesel R., Maciag T. Association of fibroblast growth factor receptor-1 with c-src correlates with association between c-src and cortactin. J. Biol. Chem. 1994; 269: 20221–20224
   PubMed Web of Science ®Google Scholar
• Zhan X., Haudenschild C. C., Ni Y., Smith E., Huang C. Upregulation of cortactin expression during the maturation of megakaryocytes. Blood 1997; 89: 457–464
   PubMed Web of Science ®Google Scholar
• Zigmond S. H. Signal transduction and actin filament assembly. Curr. Opin. Cell Biol. 1996; 8: 66–73
   PubMed Web of Science ®Google Scholar